Yuta Yokoyama

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - nucleic acidsMolecular medicineMolecular targetsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2025
Identification of risk factors and development of a predictive model in patients using cefmetazole for international normalized ratio elevation.

Takaya Namiki, Yuta Yokoyama, Motonori Kimura

|Nov 20, 2023
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended-Spectrum β-lactamase producing Enterobacterales (ESBL-E).

Takaya Namiki, Yuta Yokoyama, Hideki Hashi

|Jan 24, 2023
Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents.

Fumihiro Kikuyama, Sayo Suzuki, Aya Jibiki

|Jan 13, 2023
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.

Emi Ishikawa, Yuta Yokoyama, Haruna Chishima

|Jul 12, 2022
Simultaneous quantification of dasatinib, nilotinib, bosutinib, and ponatinib using high-performance liquid chromatography-Photodiode array detection.

Yuta Yokoyama, Eiji Nozawa, Miho Morita

Pageof 1

Frequent Collaborators

4 joint publications

Sayo Suzuki

3 joint publications

Aya Jibiki

3 joint publications

Hitoshi Kawazoe

3 joint publications

Tomonori Nakamura